New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.

Oncolytic viruses (OVs) are viruses that infect and kill cancer cells while sparing healthy tissue, making them a promising therapeutic option in cancer ...

Transarterial chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular carcinoma (HCC). The optimal schedule, best anticancer agent and best technique are still unclear.

"Typically, patients treated with systemic therapy for locally advanced hepatocellular carcinoma recur within ... referred to as macrovascular invasion (MVI), is associated with increased risk ...

A new prognostic model could potentially predict and stratify the risk for hepatocellular carcinoma (HCC) among patients with chronic hepatitis B (CHB) who are noncirrhotic and not indicated for ...